Skip to main content

Table 1 Patient Demographics

From: Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system

 

Manual Alerts

PHS Alerts

P

Demographics

   

  Patients, n

3497

3781

 

  Duration (days)

501

488

 

  Patient-years

2,883

3,367

 

  Male (%)

1,885 (53)

1,996 (52.8)

0.83

  Age

   

    Mean ± SD

59.6 ± 17.8

59.0 ± 18.0

0.12

    < 20

125 (3.6%)

156 (4.1%)

0.7

    20-29

99 (2.8%)

110 (2.9%)

 

    30-39

203 (5.8%)

234 (6.2%)

 

    40-49

456 (13.0%)

471 (12.5%)

 

    50-59

687 (19.6%)

784 (20.7%)

 

    60-69

784 (22.4%)

843 (22.3%)

 

    71-80

759 (21.7%)

779 (20.6%)

 

    >80

384 (11.0)

404 (10.7%)

 

  Underlying Diseases

Case (%)

Case (%)

0.11

    Hypertension

920 (26)

1,047 (28)

 

    Diabetes mellitus

556 (16)

571 (15)

 

    Malignancy

248 (7)

279 (7)

 

  Treatment Indications

Case (%)

Case (%)

0.74

    Atrial flutter/atrial fibrillation

950 (27)

1,102 (29)

 

    Arterial embolism/deep venous thrombosis

626 (18)

667 (18)

 

    Cerebral vascular disease

493 (14)

529 (14)

 

    Coronary artery disease

429 (12)

502 (13)

 

    Heart failure

425 (12)

455 (12)

 

    Coagulation factor abnormality

236 (7)

255 (7)

 

    Other cardiovascular diseases

202 (6)

248 (7)

 

    Pulmonary embolism

39 (1)

52 (1)

Â